Caprion Awarded $12.9M Infectious Disease Biomarker Research Contract | GenomeWeb
NEW YORK (GenomeWeb News) – Montreal-based Caprion Proteomics has won a $12.9 million contract from the National Institute of Allergy and Infectious Diseases to research biomarkers for infectious diseases, the company said today.
Under the five-year contract, Caprion will act as one of two NIAID Clinical Proteomics Centers for Infectious Disease and Biodefense.
The company will use its CellCarta protein profiling technology to conduct large-scale applied proteomics projects on human clinical samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.